OTCMKTS:MYRX - Myrexis Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.0350 +0.01 (+40.00 %)
(As of 02/18/2019 12:11 PM ET)
Previous Close$0.03
Today's Range$0.03 - $0.0395
52-Week Range$0.0070 - $0.0572
Volume163,250 shs
Average Volume188,975 shs
Market Capitalization$1.21 million
P/E RatioN/A
Dividend YieldN/A
Beta4.23
Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.

Receive MYRX News and Ratings via Email

Sign-up to receive the latest news and ratings for MYRX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:MYRX
CUSIPN/A
Phone801-214-7800

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Market Cap$1.21 million
OptionableNot Optionable

Myrexis (OTCMKTS:MYRX) Frequently Asked Questions

What is Myrexis' stock symbol?

Myrexis trades on the OTCMKTS under the ticker symbol "MYRX."

Has Myrexis been receiving favorable news coverage?

Media stories about MYRX stock have trended somewhat positive on Monday, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Myrexis earned a media sentiment score of 1.6 on InfoTrie's scale. They also gave media headlines about the biopharmaceutical company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the near term.

Who are some of Myrexis' key competitors?

Who are Myrexis' key executives?

Myrexis' management team includes the folowing people:
  • Mr. Jonathan M. Couchman, Chairman, CEO, Pres, CFO and Principal Accounting Officer (Age 49)

How do I buy shares of Myrexis?

Shares of MYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Myrexis' stock price today?

One share of MYRX stock can currently be purchased for approximately $0.0350.

How big of a company is Myrexis?

Myrexis has a market capitalization of $1.21 million.

What is Myrexis' official website?

The official website for Myrexis is http://www.myrexis.com.

How can I contact Myrexis?

Myrexis' mailing address is C/O XSTELOS HOLDINGS INC. 630 FIFTH AVENUE SUITE 2260, NEW YORK NY, 10020. The biopharmaceutical company can be reached via phone at 801-214-7800 or via email at [email protected]


MarketBeat Community Rating for Myrexis (OTCMKTS MYRX)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  53 (Vote Outperform)
Underperform Votes:  42 (Vote Underperform)
Total Votes:  95
MarketBeat's community ratings are surveys of what our community members think about Myrexis and other stocks. Vote "Outperform" if you believe MYRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MYRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2019 by MarketBeat.com Staff

Featured Article: Preferred Stock

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel